Jon Blatchford

3.4k citations
21 papers · 2.5k · 3 hit papers · h-index 13

Impact in

    • Heart Failure Treatment and Management
    • Atrial Fibrillation Management and Outcomes
    • Cardiac Valve Diseases and Treatments
    • Antiplatelet Therapy and Cardiovascular Diseases
    • Venous Thromboembolism Diagnosis and Management

Papers in

Jon Blatchford

21 papers receiving 2.4k citations

Jon Blatchford's Hit Papers

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial 2022 · 679 citations
6790+4+8Years since publication2505007501k

Peers

Jon Blatchford
Comparison fields: 5 of 70
  • Cardiology and Cardiovascular Medicine 1.8k
  • Internal Medicine 171
  • Endocrinology, Diabetes and Metabolism 347
  • Hematology 90
  • Neurology 77
Replace PABLO OMAR SCHYGIEL with:
PABLO OMAR SCHYGIEL Canada
Steven Lupovitch United States
CLAUDIO RODOLFO MAJUL Argentina
Marisa L. Vico United States
Peter H. Held Sweden
В. А. Марков Russia
Abraham S. Salacata United States
Anders Gorst‐Rasmussen Denmark
Michael Hanna United States
Ellis W. Lader United States
Jon Blatchford relative to PABLO OMAR SCHYGIEL Canada PABLO OMAR SCHYGIEL's profile →
Citations per field
00.5×5×10.4×
PABLO OMAR SCHYGIEL · 1×
Citations per year

Countries citing papers authored by Jon Blatchford

Since Specialization
Citations

This map shows the geographic impact of Jon Blatchford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Blatchford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Blatchford more than expected).

Fields of papers citing papers by Jon Blatchford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Blatchford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Blatchford. The network helps show where Jon Blatchford may publish in the future.

Co-authors

The 25 scholars most cited alongside Jon Blatchford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jon Blatchford Line = papers co-authored together Jon Blatchford links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
Hit paper breakdown →
20131134
2
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
Hit paper breakdown →
2022679
3
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial
Hit paper breakdown →
2022168
4 2022113
5 202173
6
Efficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studies.
201071
7 201270
8 201660
9 202240
10 202335
11 201725
12 201218
13 202416
14 202311
15 201710
16 20225
17 20244
18 20242
19 20191
20 20231

About Jon Blatchford

Jon Blatchford is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Geriatrics and Gerontology, Toxicology and Physiology, having authored 21 papers that have together received 2.5k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (12 papers), Atrial Fibrillation Management and Outcomes (2 papers), Asthma and respiratory diseases (2 papers), Diabetes Treatment and Management (2 papers), Acute Ischemic Stroke Management (1 paper), Blood Pressure and Hypertension Studies (1 paper), Pharmaceutical Practices and Patient Outcomes (1 paper) and Cerebrovascular and genetic disorders (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (1.8k citations), Internal Medicine (171 citations), Endocrinology, Diabetes and Metabolism (347 citations), Hematology (90 citations) and Neurology (77 citations). Jon Blatchford has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Martina Brueckmann, Frans Van de Werf, Ruth Harper, Maarten L. Simoons, John W. Eikelboom, Maximilian T. Lobmeyer, Michael J. Mack, Hugo J. Maas, A. Pieter Kappetein and Yasser Khder. Their work appears in journals such as European Journal of Heart Failure, Stroke, International Journal of Pharmacy Practice, Allergy and Asthma Proceedings and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact